As the industry gathers at INTERPHEX Week Tokyo, we’re excited to share how KBI Biopharma is redefining the possibilities of drug development and manufacturing. Whether you’re looking to scale complex biologics or accelerate your path to clinic, our team is ready to discuss how our integrated capabilities and global expertise can support your mission. Stop by booth #18-47 to connect with us and discover how we can transform your most ambitious science into life-changing therapies.
Schedule a meeting >>
Meet with the KBI Biopharma Team:
KBI Biopharma is a leading global contract development and manufacturing organization (CDMO) providing fully integrated, accelerated drug development and biologics manufacturing services and expertise to life science companies. With each of our 1400+ client partners, we work closely to personalize and accelerate drug development programs. Built upon a foundation of world-class analytics capabilities and extensive scientific and technical expertise, we deliver robust process development and clinical and commercial cGMP manufacturing services for mammalian and microbial programs. Recognized for quality manufacturing, we help clients advance drug candidates into the clinic and beyond.
Learn more about KBI Biopharma >>
Recognized as Asia's leading trade show for the pharmaceutical and biotechnology industries, the event serves as a comprehensive "one-stop" platform covering everything from drug discovery and R&D to manufacturing and packaging. The 2026 edition will feature six specialized exhibitions, including the debut of the CMO/CDMO EXPO, alongside established shows like BioPharma Expo and Pharma Digital Transformation Expo. With over 950 exhibitors and an expected 35,000 visitors, the week provides a critical hub for global professionals to explore cutting-edge technologies, such as regenerative medicine and AI-driven drug discovery, while fostering international business collaborations across the life sciences sector.